Protection against Omicron BA.5 from Previous Infection Conventional wisdom is that previous
infection with omicron subvariant BA.1 or BA.2 does not protect against BA.5, but data …

(A) Incidence of documented SARS-CoV-2 infection overlaid with the period of dominance
of the BA. 1 and BA. 2 variants, Jan 1–Apr 14, 2022, divided into 15-day sub-intervals (shades …

Infections by the Epstein-Barr virus (EBV) are often at the disease onset of patients suffering
from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). However, serological …

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis (MS)
are two complex and multifactorial diseases whose patients experience persistent fatigue, …

Simple Summary An epidemiologic control of infectious diseases through the creation of
infectious disease surveillance systems can be achieved with routine collection and analysis of …

The SARS-CoV-2 omicron BA.5 subvariant is progressively displacing earlier subvariants,
BA.1 and BA.2, in many countries. One possible explanation is the ability of BA.5 to evade …

SARS-CoV-2 omicron subvariants BA.1 and BA.2 became dominant in many countries in
early 2022. These subvariants are now being displaced by BA.4 and BA.5. While natural …

Evidence suggests that animals are selected to make accurate choices and prioritize goals
within the constraints of a given social environment to maximize fitness. These decisions are …

Misdiagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) can occur
when different case definitions are used by clinicians (relative misdiagnosis) or when failing …

People with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) often report a
high frequency of viral infections and flu-like symptoms during their disease course. Given that …